• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巢蛋白是内皮祖细胞血管生成潜能的新伙伴。

Nestin is a New Partner in Endothelial Colony Forming Cell Angiogenic Potential.

作者信息

Cras Audrey, Larghero Jérôme, Rossi Elisa, Blandinières Adeline, Gaussem Pascale, Smadja David M

机构信息

Université de Paris Cité, INSERM, Innovative Therapies in Hemostasis, F-75006, Paris, France.

Cell therapy unit, AP-HP, Saint Louis Hospital, F-75010, Paris, France.

出版信息

Stem Cell Rev Rep. 2023 Oct;19(7):2541-2550. doi: 10.1007/s12015-023-10587-1. Epub 2023 Jul 15.

DOI:10.1007/s12015-023-10587-1
PMID:37452965
Abstract

Nestin, an intermediate filament protein expressed by progenitor cells, is associated with tissue regeneration. Although nestin expression has been reported in poorly differentiated and newly formed blood vessels, its role in endothelial cells remains unclear. In this study, we investigated the involvement of nestin in the angiogenic properties of endothelial colony-forming cells (ECFCs) derived from human umbilical cord blood. Our results demonstrate that ECFCs express high levels of nestin, and that its inhibition by small interfering RNAs decreased ECFC proliferation, migration in response to SDF-1 and VEGF-A, tubulogenesis, and adhesion on collagen. These effects are associated with modulation of focal adhesion kinase phosphorylation. Furthermore, nestin silencing resulted in reduced revascularization in a mouse hindlimb ischemia model. In conclusion, these findings provide evidence that nestin more than being a structural protein, is an active player in ECFC angiogenic properties.

摘要

巢蛋白是一种由祖细胞表达的中间丝蛋白,与组织再生相关。尽管已有报道称巢蛋白在低分化和新形成的血管中表达,但其在内皮细胞中的作用仍不清楚。在本研究中,我们调查了巢蛋白在源自人脐带血的内皮集落形成细胞(ECFCs)血管生成特性中的作用。我们的结果表明,ECFCs表达高水平的巢蛋白,并且小干扰RNA对其的抑制作用降低了ECFC的增殖、对SDF-1和VEGF-A的迁移反应、管腔形成以及在胶原蛋白上的黏附。这些效应与粘着斑激酶磷酸化的调节有关。此外,在小鼠后肢缺血模型中,巢蛋白沉默导致血管再生减少。总之,这些发现提供了证据,表明巢蛋白不仅仅是一种结构蛋白,还是ECFC血管生成特性中的一个活跃参与者。

相似文献

1
Nestin is a New Partner in Endothelial Colony Forming Cell Angiogenic Potential.巢蛋白是内皮祖细胞血管生成潜能的新伙伴。
Stem Cell Rev Rep. 2023 Oct;19(7):2541-2550. doi: 10.1007/s12015-023-10587-1. Epub 2023 Jul 15.
2
ECFC-derived exosomal THBS1 mediates angiogenesis and osteogenesis in distraction osteogenesis via the PI3K/AKT/ERK pathway.内皮祖细胞衍生的外泌体凝血酶敏感蛋白1通过PI3K/AKT/ERK途径介导牵张成骨中的血管生成和成骨作用。
J Orthop Translat. 2022 Sep 23;37:12-22. doi: 10.1016/j.jot.2022.08.004. eCollection 2022 Nov.
3
NOX4 is a major regulator of cord blood-derived endothelial colony-forming cells which promotes post-ischaemic revascularization.NOX4 是脐血衍生内皮集落形成细胞的主要调节因子,可促进缺血后再血管化。
Cardiovasc Res. 2020 Feb 1;116(2):393-405. doi: 10.1093/cvr/cvz090.
4
CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.CD34 杂交细胞促进内皮细胞集落形成细胞的生物活性和治疗缺血性疾病的潜力。
Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1622-34. doi: 10.1161/ATVBAHA.112.301052. Epub 2013 May 2.
5
CD34 expression modulates tube-forming capacity and barrier properties of peripheral blood-derived endothelial colony-forming cells (ECFCs).CD34表达调节外周血来源的内皮集落形成细胞(ECFCs)的管腔形成能力和屏障特性。
Angiogenesis. 2016 Jul;19(3):325-38. doi: 10.1007/s10456-016-9506-9. Epub 2016 Apr 4.
6
Sphingosine kinase 1 expressed by endothelial colony-forming cells has a critical role in their revascularization activity.内皮祖细胞表达的鞘氨醇激酶 1 在其血管生成活性中具有关键作用。
Cardiovasc Res. 2014 Jul 1;103(1):121-30. doi: 10.1093/cvr/cvu104. Epub 2014 Apr 17.
7
Tetraspanin CD151 and integrin α6β1 mediate platelet-enhanced endothelial colony forming cell angiogenesis.四跨膜蛋白CD151和整合素α6β1介导血小板增强的内皮祖细胞血管生成。
J Thromb Haemost. 2016 Mar;14(3):606-18. doi: 10.1111/jth.13248. Epub 2016 Feb 11.
8
Ceramide 1-Phosphate Protects Endothelial Colony-Forming Cells From Apoptosis and Increases Vasculogenesis In Vitro and In Vivo.神经酰胺 1-磷酸可防止体外和体内的内皮祖细胞凋亡,并增加血管生成。
Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):e219-e232. doi: 10.1161/ATVBAHA.119.312766. Epub 2019 Aug 22.
9
Acidic preconditioning of endothelial colony-forming cells (ECFC) promote vasculogenesis under proinflammatory and high glucose conditions in vitro and in vivo.内皮祖细胞(ECFC)的酸性预处理可促进体外和体内炎症和高血糖条件下的血管生成。
Stem Cell Res Ther. 2018 May 2;9(1):120. doi: 10.1186/s13287-018-0872-7.
10
Human Endothelial Colony Forming Cells Express Intracellular CD133 that Modulates their Vasculogenic Properties.人内皮祖细胞表达细胞内 CD133,调节其血管生成特性。
Stem Cell Rev Rep. 2019 Aug;15(4):590-600. doi: 10.1007/s12015-019-09881-8.

引用本文的文献

1
The role of vascularity and the fibrovascular interface in interstitial lung diseases.血管形成及纤维血管界面在间质性肺疾病中的作用。
Eur Respir Rev. 2025 Feb 5;34(175). doi: 10.1183/16000617.0080-2024. Print 2025 Jan.
2
Endothelial heterogeneity in bone marrow: insights across development, adult life and leukemia.骨髓中的内皮异质性:发育、成年期及白血病中的见解
Leukemia. 2025 Jan;39(1):8-24. doi: 10.1038/s41375-024-02453-x. Epub 2024 Nov 11.
3
The role of vasculature and angiogenesis in respiratory diseases.血管和血管生成在呼吸疾病中的作用。

本文引用的文献

1
Human CD34 very small embryonic-like stem cells can give rise to endothelial colony-forming cells with a multistep differentiation strategy using UM171 and nicotinamide acid.人类CD34+非常小的胚胎样干细胞可以利用UM171和烟酰胺酸,通过多步骤分化策略产生内皮集落形成细胞。
Leukemia. 2022 May;36(5):1440-1443. doi: 10.1038/s41375-022-01517-0. Epub 2022 Feb 15.
2
Gonadotropins as novel active partners in vascular diseases: Insight from angiogenic properties and thrombotic potential of endothelial colony-forming cells.促性腺激素作为血管疾病中的新型活性伴侣:内皮祖细胞的血管生成特性和血栓形成潜能的启示。
J Thromb Haemost. 2022 Jan;20(1):230-237. doi: 10.1111/jth.15549. Epub 2021 Oct 29.
3
Angiogenesis. 2024 Aug;27(3):293-310. doi: 10.1007/s10456-024-09910-2. Epub 2024 Apr 5.
4
Recent advances in endothelial colony-forming cells: from the transcriptomic perspective.内皮祖细胞的最新进展:从转录组学角度看。
J Transl Med. 2024 Mar 26;22(1):313. doi: 10.1186/s12967-024-05108-8.
Differential Angiogenic Responses of Human Endothelial Colony-Forming Cells to Different Molecular Subtypes of Breast Cancer Cells.
人内皮祖细胞对不同分子亚型乳腺癌细胞的差异性血管生成反应
J Lipid Atheroscler. 2021 Jan;10(1):111-122. doi: 10.12997/jla.2021.10.1.111. Epub 2021 Jan 18.
4
ERG and nestin: useful markers of immature vessels and novel prognostic markers in renal cell carcinoma.视网膜电图和巢蛋白:肾细胞癌中未成熟血管的有用标志物及新型预后标志物
Int J Clin Exp Pathol. 2021 Jan 1;14(1):116-125. eCollection 2021.
5
Endothelial Colony-Forming Cells from Idiopathic Pulmonary Fibrosis Patients Have a High Procoagulant Potential.特发性肺纤维化患者的内皮祖细胞具有较高的促凝潜能。
Stem Cell Rev Rep. 2021 Apr;17(2):694-699. doi: 10.1007/s12015-020-10043-4. Epub 2020 Sep 24.
6
Valproic Acid Decreases Endothelial Colony Forming Cells Differentiation and Induces Endothelial-to-Mesenchymal Transition-like Process.丙戊酸可减少内皮祖细胞的分化,并诱导内皮细胞向间充质细胞转化样过程。
Stem Cell Rev Rep. 2020 Apr;16(2):357-368. doi: 10.1007/s12015-019-09950-y.
7
Vasculogenic Stem and Progenitor Cells in Human: Future Cell Therapy Product or Liquid Biopsy for Vascular Disease.人源血管生成干细胞与前体细胞:血管疾病的未来细胞治疗产品或液体活检
Adv Exp Med Biol. 2019;1201:215-237. doi: 10.1007/978-3-030-31206-0_11.
8
Standardization of methods to quantify and culture endothelial colony-forming cells derived from peripheral blood: Position paper from the International Society on Thrombosis and Haemostasis SSC.外周血来源的内皮祖细胞定量及培养方法的标准化:国际血栓与止血学会科学与标准化委员会立场文件
J Thromb Haemost. 2019 Jul;17(7):1190-1194. doi: 10.1111/jth.14462. Epub 2019 May 22.
9
Human Endothelial Colony Forming Cells Express Intracellular CD133 that Modulates their Vasculogenic Properties.人内皮祖细胞表达细胞内 CD133,调节其血管生成特性。
Stem Cell Rev Rep. 2019 Aug;15(4):590-600. doi: 10.1007/s12015-019-09881-8.
10
Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity.特发性肺纤维化患者分离的内皮祖细胞释放白细胞介素-8 可能有助于其发病机制。
Angiogenesis. 2019 May;22(2):325-339. doi: 10.1007/s10456-018-09659-5. Epub 2019 Jan 3.